Skip to primary navigation Skip to main content
0 item $0.00

A researcher clinician, Thomas Marwick is the Director and Chief Executive of the Baker Heart and Diabetes Institute

Thomas Marwick is a foundation member of the Australian Academy of Health and Medical Sciences, recipient of personal awards and honours (including the Eccles award of the National Health and Medical Research Council of Australia), associate editor of the Journal of the American College of Cardiology (JACC), deputy editor of JACC-Cardiovascular Imaging, and former Chair of the Heart Foundation’s National Research Committee.

He trained at Melbourne University, the University of Louvain and Harvard University, and has an outstanding track record with regards publications and attracting grant support. A cardiologist, he has a focus on health outcomes and holds particular expertise in cardiac imaging in heart failure and coronary disease, and the detection of early stages of cardiac dysfunction.

Prior to joining The Baker Institute, he was Director of the Menzies Institute for Medical Research in Tasmania. In addition, he has provided significant research and clinical leadership at the Cleveland Clinic in Ohio (Head of Cardiovascular Imaging ), the University of Queensland (Head, UQ Section of Medicine, Southern Clinical Division) and the Princess Alexandra Hospital (Director of Echocardiography) in Brisbane.

Qualifications

MBBS (Hons) University of Melbourne (1981)
PhD University of Louvain, Belgium (1994)
MPH Harvard School of Public Health (2011)

Memberships

Founding member Australian Cardiovascular Alliance (2015–)
Founding member Australian Academy of Health and Medical Sciences (2013–)
Associate editor Journal of American College of Cardiology (2013–)
Deputy editor JACC-Cardiovascular Imaging (2008–)

Editorial boards

American Heart Journal
(including guest editor 1997 and 2003)
1996–
Cardiovascular Ultrasound Journal 2002–
Journal of the American Society of Echocardiography 2001–04
International Journal of Cardiovascular Imaging 2003–15
Korean Journal of Cardiovascular Disease 2002–
Heart 2004–

Fellowships

FRACP 1988
FACC 1993
FRCP 2008
FAHMS 2014

Awards/honours

Patron's Prize for Clinical Research, Royal Prince Alfred Hospital 1987
Traveling scholarship, International Federation of Nuclear Medicine and Biology 1990
Cardiology Research Prize, Cleveland Clinic 1990
Cardiology Dept of Cleveland Clinic, Distinguished Teacher Award 1991
Cleveland Clinic Traveling Fellowship 1991
Cardiovascular Young Investigator Award, Society of Nuclear Medicine 1992
Award of Excellence in Education, American Society of Associations (awarded to ACCSAP CD-ROM contributors) 1998
Eccles award, National Health and Medical Research Foundation of Australia 1999
Feigenbaum Lecturer, American Society of Echocardiography 2003
Euroecho Lecturer, European Association of Echocardiography 2004
RT Hall Prize, Cardiac Society of Australia and New Zealand 2006
President’s Award, National Heart Foundation of Australia 2007
Simon Dack Award, American College of Cardiology 2009
The John H. Tyrer Prize for Research in Internal Medicine, University of Qld 2009
Kempson Maddox lecture, Cardiac Society of Australia and New Zealand 2011

Research interests

Professor Marwick is interested in the use of cardiovascular imaging techniques to detect disease at the preclinical phase, at which time, early treatment may prevent progression to overt disease. He is also interested in the quality, appropriateness and cost-effectiveness of cardiovascular imaging.

Research projects

CAUGHT-CAD
An Australia-wide, multicentre randomised trial of CT-guided therapy for individuals with a family history of coronary artery disease. Supported by an NHMRC Project Grant.

SUCCOUR
An international, multicentre randomised trial of strain-guided therapy for individuals taking potentially cardiotoxic chemotherapy. Supported by an NHMRC Project Grant.

TasELF
A community-based study of early detection of heart failure in at risk individuals >65 years old. Supported by the Tasmanian community fund, and grants from Siemens Healthcare and Menarini Pharmaceuticals.

TasHELP
A Statewide initiative to reduce readmissions with heart failure, supported by an NHMRC Partnership Grant.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more